Published May 8, 2019
| Version v1
Dataset
Open
Testing Selectivity of USP5 Zf-UBD Analogues with SPR Assay
Authors/Creators
- 1. University of Toronto, Structural Genomics Consortium
Description
A surface plasmon resonance (SPR) assay is used to determine binding affinities of commercial compound analogues against the zinc finger ubiquitin binding domain (Zf-UBD) of USP5 and test for selectivity against HDAC6 Zf-UBD
Notes
The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.